Elana Cherry

640 total citations
8 papers, 191 citations indexed

About

Elana Cherry is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Elana Cherry has authored 8 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Virology and 3 papers in Molecular Biology. Recurrent topics in Elana Cherry's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (2 papers). Elana Cherry is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (2 papers). Elana Cherry collaborates with scholars based in Canada and Israel. Elana Cherry's co-authors include Daishi Fujita, Ivan Babić, Mark A. Wainberg, Liwei Rong, Chen Liang, Lawrence Kleiman, Michael Laughrea, Moshe Kotler, Yudong Quan and Nathalie Morin and has published in prestigious journals such as Journal of Molecular Biology, Oncogene and Journal of Virology.

In The Last Decade

Elana Cherry

8 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elana Cherry Canada	8	120	104	96	19	18	8	191
Alok Mulky United States	9	184 1.5×	232 2.2×	127 1.3×	46 2.4×	49 2.7×	10	375
Chi-I Chiang United States	9	106 0.9×	65 0.6×	64 0.7×	88 4.6×	30 1.7×	11	205
Farshad C. Azimi Canada	6	75 0.6×	62 0.6×	54 0.6×	24 1.3×	41 2.3×	7	151
Simon Dustan United Kingdom	6	127 1.1×	33 0.3×	99 1.0×	52 2.7×	29 1.6×	7	182
Yang-Hui Jimmy Yeh United States	8	70 0.6×	108 1.0×	44 0.5×	56 2.9×	36 2.0×	11	205
Lauren Margolin United States	8	146 1.2×	38 0.4×	115 1.2×	30 1.6×	22 1.2×	11	221
Margarita Matías‐Florentino Mexico	10	109 0.9×	103 1.0×	150 1.6×	12 0.6×	41 2.3×	19	265
Ujjwal Rathore India	6	70 0.6×	64 0.6×	35 0.4×	38 2.0×	32 1.8×	8	137
Katharine M. Jenike United States	6	86 0.7×	66 0.6×	64 0.7×	40 2.1×	21 1.2×	10	168
Bilguujin Dorjsuren United States	3	99 0.8×	224 2.2×	29 0.3×	14 0.7×	10 0.6×	3	261

Countries citing papers authored by Elana Cherry

Since Specialization

Citations

This map shows the geographic impact of Elana Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elana Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elana Cherry more than expected).

Fields of papers citing papers by Elana Cherry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elana Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elana Cherry. The network helps show where Elana Cherry may publish in the future.

Co-authorship network of co-authors of Elana Cherry

This figure shows the co-authorship network connecting the top 25 collaborators of Elana Cherry. A scholar is included among the top collaborators of Elana Cherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elana Cherry. Elana Cherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Babić, Ivan, Elana Cherry, & Daishi Fujita. (2006). SUMO modification of Sam68 enhances its ability to repress cyclin D1 expression and inhibits its ability to induce apoptosis. Oncogene. 25(36). 4955–4964. 61 indexed citations

Morin, Nathalie, et al.. (1999). Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication.. PubMed. 1(3). 240–7. 9 indexed citations

Liang, Chen, Liwei Rong, Elana Cherry, et al.. (1999). Deletion Mutagenesis within the Dimerization Initiation Site of Human Immunodeficiency Virus Type 1 Results in Delayed Processing of the p2 Peptide from Precursor Proteins. Journal of Virology. 73(7). 6147–6151. 27 indexed citations

Cherry, Elana, Liang Chen, Liwei Rong, et al.. (1998). Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins 1 1Edited by J. Karn. Journal of Molecular Biology. 284(1). 43–56. 36 indexed citations

Cherry, Elana, et al.. (1998). Neutralizing Antibodies Directed against the V3 Loop Select for Different Escape Variants in a Virus with Mutated Reverse Transcriptase (M184V) Than in Wild-Type Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 14(9). 735–740. 15 indexed citations

Cherry, Elana, et al.. (1998). Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication. AIDS. 12(9). 967–975. 16 indexed citations

Cherry, Elana, Margaret R. Slater, Horacio Salomón, Erling W. Rud, & M A Wainberg. (1997). Mutations at codon 184 in simian immunodeficiency virus reverse transcriptase confer resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine. Antimicrobial Agents and Chemotherapy. 41(12). 2763–2765. 13 indexed citations

Liang, Chen, Libin Rong, Nathalie Morin, et al.. (1997). The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA. Journal of Virology. 71(12). 9075–9086. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact